MaryPeace McRae, PharmD, PhD
Graduate Program Director
Associate Professor
Department of Pharmacotherapy & Outcomes Science
Faculty/Staff picture [View Image]
  •   Smith Building, Room 652B
  • School of Pharmacy
    Dept of Pharmacotherapy & Outcomes Science

    410 N 12th Street
    P.O. Box 980533
    Richmond, VA 23298-0533
  •  (804) 628-5076
    (804) 828-0343

Area of Focus

  • Drug Transporters
  • Blood brain barrier
  • HIV
  • NeuroAIDS
  • Drugs of Abuse


  • Pharm.D., (Virginia Commonwealth University, 2000)
  • Ph.D., Pharmaceutical Sciences (University of North Carolina at Chapel Hill, 2005)

Professional Experience

  • (2006 - 2011) Assistant Professor, Department of Pharmacology, Kansas City University of Medicine and Biosciences
  • (2011 - 2012) Associate Professor, Department of Pharmacology, Kansas City University of Medicine and Biosciences
  • (2012 - Present) Assistant Professor, Department of Pharmacotherapy and Outcomes Science, VCU School of Pharmacy

Professional and Scholarly Interests

  • American Society of Clinical Pharmacology and Experimental Therapeutics


Recent Publications

  • Clay PG, McRae M, Laurent JP. Safety, Tolerability, and Pharmacokinetics of KP-1461 in Phase I Clinical Studies: A Single Oral Dose Study in Non-HIV-Infected Adults, and a 14-Day Dose-Escalating Study in Highly Antiretroviral-Experienced HIV-Infected Adults, J Int Assoc Physicians AIDS Care, 2011 Jul-Aug; 10(4):232-8.
  • Clay PG, Adiga R, Taylor TAH, Alsup R, Gerk PM, McRae, MP. Postpartum Pharmacokinetics of Peramivir in the Treatment of Influenza H1N1: A Case Report, Obstetrics & Gynecology, 2011 Aug; 118(2 Pt 2):463-7.
  • Hicks C, Clay P, Redfield R, Lalezari J, Liporace R, Ramirez JM, Schneider S, Sension M, DeGruttola V, Hughes J, McRae MP, Laurent JP, Safety, Tolerability and Efficacy of KP-1461 as Monotherapy for 124 Days in Antiretroviral-Experienced, HIV-1-Infected Subjects. AIDS Research and Human Retroviruses, 2012 Jun 28.
  • Dever, SM, Costin BN, Xu R, El-Hage N, Balinang J, Samoshkin A, O’Brien MA, McRae MP, Diatchenko L, Knapp PE, Hauser KF. 2013. Differential expression of the alternatively-spliced OPRM1 isoform MOR-1K in HIV-infected Subjects. AIDS, 2014 Jan 2; 28(1):19-30.
  • Ellis K, Marlin JW, Taylor TA, Fitting S, Hauser KF, Rice G, McRae M. The effects of human immunodeficiency virus infection on the expression of the drug efflux proteins P-glycoprotein and breast cancer resistance protein in a human intestine model. J Pharm Pharmacol, 2014 Dec 31. [Epub ahead of print]
View graphic versionView graphic version